Effect of intravenous albumin on systemic and hepatic hemodynamics and vasoactive neurohormonal systems in patients with cirrhosis and spontaneous bacterial peritonitis.
about
Intensive care management of patients with liver disease: proceedings of a single-topic conference sponsored by the Brazilian Society of HepatologyAlbumin reduces paracentesis-induced circulatory dysfunction and reduces death and renal impairment among patients with cirrhosis and infection: a systematic review and meta-analysisHaemodynamic effects of plasma-expansion with hyperoncotic albumin in cirrhotic patients with renal failure: a prospective interventional study.Renal dysfunction in patients with cirrhosis: Where do we stand?Diagnosis of spontaneous bacterial peritonitis in infants and children with chronic liver disease: A cohort study.ATTIRE: Albumin To prevenT Infection in chronic liveR failurE: study protocol for a single-arm feasibility trial.Effects of plasma expansion with albumin and paracentesis on haemodynamics and kidney function in critically ill cirrhotic patients with tense ascites and hepatorenal syndrome: a prospective uncontrolled trial.Towards goal-directed therapy of hepatorenal syndrome: we have the tools but we need the trials.Diagnosis, prevention and treatment of hepatorenal syndrome in cirrhosis.Population Based Trends in the Incidence of Hospital Admission for the Diagnosis of Hepatorenal Syndrome: 1998-2011.A randomized, prospective, double-blind, placebo-controlled trial of terlipressin for type 1 hepatorenal syndromeMedical management of ascites.Should albumin be used in all patients with spontaneous bacterial peritonitis?Current limits and future challenges in the management of renal dysfunction in patients with cirrhosis: report from the International Club of Ascites.Albumin: pathophysiologic basis of its role in the treatment of cirrhosis and its complications.Optimal management of hepatorenal syndrome in patients with cirrhosis.Review article: advances in the management of patients with cirrhosis and portal hypertension-related renal dysfunction.Recent advances in cirrhotic cardiomyopathy.Albumin in chronic liver disease: structure, functions and therapeutic implications.Role of albumin in cirrhosis: from a hospitalist's perspective.Artificial liver support in pigs with acetaminophen-induced acute liver failure.Gut flora and bacterial translocation in chronic liver disease.Restricted use of albumin for spontaneous bacterial peritonitisEffect of intravenous albumin on endotoxin removal, cytokines, and nitric oxide production in patients with cirrhosis and spontaneous bacterial peritonitis.Albumin infusion improves renal blood flow autoregulation in patients with acute decompensation of cirrhosis and acute kidney injury.Treatment of hepatorenal syndrome as defined by the international ascites club by albumin and furosemide infusion according to the central venous pressure: a prospective pilot study.MARS and the failing liver-Any help from the outer space?A reproducible, clinically relevant, intensively managed, pig model of acute liver failure for testing of therapies aimed to prolong survival.Type of edema in posterior reversible encephalopathy syndrome depends on serum albumin levels: an MR imaging study in 28 patients.Spontaneous bacterial and fungal peritonitis in patients with liver cirrhosis: A literature review.Brexit from current guideline recommendations?ATTIRE: Albumin To prevenT Infection in chronic liveR failurE: study protocol for an interventional randomised controlled trialIntensive Care Therapy for Patients with Advanced Liver Diseases
P2860
Q26865028-1E2FBAF1-12EC-4824-BF10-8F9661903A0EQ27009006-B4368A23-7EF9-487D-9AED-DFC87F279918Q33364276-6F88C963-5E77-48DF-B148-4FA11E066745Q34047665-4DDD7CC8-EE6A-4BEF-A7F3-843FD87BDDB5Q35063881-002069E2-AD58-452C-9676-210EC29ABA60Q36527179-8F6CADA7-77F5-4A7A-BC9F-31A4C5DB7D56Q36642098-3BF22366-E926-48D9-A31E-3A9867DA734DQ36748911-F4989B1B-0540-4A17-8C54-3FCAFA8AA49BQ36772257-2F15F478-5161-4A6B-A6B8-2E89D2096666Q36814530-F8A9A7A6-F810-437B-9E8F-9A2ABE5C6126Q37061659-AB5602CE-BB2C-422E-93CB-67FF2B5CC668Q37838441-800C1ECC-C0B4-4F5B-ADCA-D99258972261Q37923785-F8AFE3DA-AB16-4301-9CA5-E99624676874Q38002958-38A8359B-4038-43C7-A404-285313819E36Q38083035-9D1490CC-FFD1-4FD0-8440-0673A4221302Q38173738-29482C0E-C850-4FEB-910A-BB438773BB7BQ38188048-BB3A33EF-F6E8-46EE-A4DA-881E81BF52E4Q38268965-348A002F-3EF9-4F12-991C-8601BEFF155DQ38595462-3B9B9B4C-25D7-46E8-B4E4-10F075E9D1E0Q39387113-35A912A2-49CB-4A22-AC3A-0F0ACE52832DQ42261846-38EFFD35-E836-47E1-BD83-ECAA93535AC5Q42774107-3599D03A-897B-4B5B-A403-B18F6AC6FD4AQ42843083-7E399FAE-8EAF-4A0D-AFFE-D1C0BE9FCA51Q43812247-3D174768-672C-4507-8711-9A74E181020AQ44470119-359C9041-93CD-430B-A953-2C134304D4BEQ46879540-7E00DF74-A7A8-43D5-AA42-A18CE9152C8FQ50854199-2D2C9107-52E2-4175-8077-66628114AFECQ51279732-E4D7C4D9-3E01-42CD-A695-E6599E25273FQ51611416-68208E5E-3486-417B-9A77-4296230DA48EQ53703031-48ACD32D-1C7F-448D-B360-E9BF25035C72Q54115392-ABC96020-0679-4197-8295-653DDAE677A2Q57806275-2C11473E-ED21-4055-9CEE-E81142DDDA87Q57824678-60F5D864-468D-48E4-8F8C-AE3DCC986385
P2860
Effect of intravenous albumin on systemic and hepatic hemodynamics and vasoactive neurohormonal systems in patients with cirrhosis and spontaneous bacterial peritonitis.
description
2004 nî lūn-bûn
@nan
2004年の論文
@ja
2004年学术文章
@wuu
2004年学术文章
@zh
2004年学术文章
@zh-cn
2004年学术文章
@zh-hans
2004年学术文章
@zh-my
2004年学术文章
@zh-sg
2004年學術文章
@yue
2004年學術文章
@zh-hant
name
Effect of intravenous albumin ...... taneous bacterial peritonitis.
@en
Effect of intravenous albumin ...... taneous bacterial peritonitis.
@nl
type
label
Effect of intravenous albumin ...... taneous bacterial peritonitis.
@en
Effect of intravenous albumin ...... taneous bacterial peritonitis.
@nl
prefLabel
Effect of intravenous albumin ...... taneous bacterial peritonitis.
@en
Effect of intravenous albumin ...... taneous bacterial peritonitis.
@nl
P2093
P1476
Effect of intravenous albumin ...... taneous bacterial peritonitis.
@en
P2093
Jaume Bosch
Javier Fernández
Juan G-Abraldes
Miguel Navasa
Wladimiro Jiménez
P304
P356
10.1016/J.JHEP.2004.05.009
P577
2004-09-01T00:00:00Z